Niksan Pharmaceutical provides API and finished formulations of Rasagiline in many Indian states of like Karnataka, Tamil Nadu,Telangana, Maharashtra, Rajasthan, Sikkim, Tamil Nadu, Goa, Gujarat, Jammu and Kashmir,Andhra Pradesh,Telangana, Punjab, Maharashtra, West Bengal and many other states.
Niksan pharmaceutical is also large exporter of the API and finished pharmaceutical products of Rasagiline many countries for years. The countries where we exporting are Puerto Rico, UnitedStates, Ireland, Israel, United Kingdom, United States, Australia South Korea,Hong Kong, Taiwan, France , Canada, Bangladesh, Poland, Pakistan, Thailand,Netherlands, Turkey, Vietnam, Philippines, India, Iran, Canada, Indonesia,Finland, Thailand, Egypt, Vietnam, UK, Taiwan, Netherlands, Poland, Australia,Mexico, Germany etc.
Rasagiline isirreversible inhibitor of monoamine oxidase-B which is used to treatment ofearly Parkinson's disease and also used to treatment of nerves system disease.
CAS NO: 136236-51-6
MOLECULARMASS: 171.23 g/mol
STORAGE OF Rasagiline: Store it inroom temperature (20C to 25C).Store it in cool and dry place, away frommoisture and direct light.Do not store this medicine in bathroom or any humidlyplace.
APPLICATIONSOF Rasagiline: Rasagiline usedto treatment of Parkinson's disease.It is also reduce the amount of offtime(periods of slow movement or stiffness).
HOW TO USE:Rasagiline is taken by mouth with or without food.Takeregular dose for better result.Follow all direction on your prescription label.Ask your doctor if you have any confusion aboutRasagiline medication.
HOW Rasagiline WORKS: Rasagiline works by increasing the amounts ofcertain natural substances in the brain.
CONTRAINDICATIONS: If you are a patient of malignant melanoma and skincancer kindly avoid Rasagiline.Do not take Rasagiline if you havemanic-depression and psychotic disorder.Kindly avoid Rasagiline if you have anyliver problem or high and low blood pressure problem.
PHARMACOKINETICSOF Rasagiline:Rasagiline rapidly absorbed after oral administration.Halflife of Rasagiline is 3 hours.Rasagiline plasma protein binding ranges is88-94%.Peak plasma concentration of Rasagiline is 2.5 mg/ml to 4.9 mg/ml.AlmostAllRasagilineand its metabolites eliminate by liver.
SIDE EFFECTS OF Rasagiline:Commonside effects of Rasagiline are Dizziness, drowsiness, joint pain, heartburn,nausea, dry mouth and weight loss.This medicine may cause serotonin syndrome.Inthe rare case this medicine may cause high blood pressure.The very seriousallergic reaction to this medicine is rare but you see any side effect ofRasagiline kindly tell your doctor.
PRECAUTION:During the pregnancy kindly avoid Rasagiline.Before themedication share your past medical history with your doctor.This medicine maymake you dizzy so kindly avoid alcohol and cannabis.Consult with your doctorbefore the breast-feeding because it is unknown if drug passes into breastmilk.If you have any liver disease and mental disorder kindly tell your doctorbefore taking Rasagiline.
CDSCOAPPROVAL:Rasagiline(as mesylate) Tablets 0.5mg/1mg is approved by CDSCO in India in 31.01.09.
FORMULATIONSAVAILABLE IN MARKET:
Rasagiline 1 MG PILLS
Rasagiline 0.5 MG PILLS
Rasagiline (as mesylate) Tablets0.5mg/1mg
Note: Productprotected by valid patents are not offered for sale in countries where suchpatents are still valid and its liability is at Buyers Risk.